Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host.

Annals of oncology : official journal of the European Society for Medical Oncology - 1 Sept 2013

Gallagher D J, Vijai J, Hamilton R J, Ostrovnaya I, Iyer G, Garcia-Grossman I R, Kim P H, Przybylo J A, Alanee S, Riches J C, Regazzi A M, Milowsky M I, Offit K, Bajorin D F

Abstract excerpt

BACKGROUND: Variations in urothelial carcinoma (UC) response to platinum chemotherapy are common and frequently attributed to genetic and epigenetic variations of somatic DNA. We hypothesized that variations in germline DNA may contribute to UC chemosensitivity. PATIENTS AND METHODS: DNA from 210...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carboplatin

Share to Cisplatin

Share to Drug Resistance, Neoplasm

Share to Germ-Line Mutation

Share to Urologic Neoplasms

Share to Urothelium

Source

Identifiers

PMID: 23897706
DOI: 10.1093/annonc/mdt225

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23897706-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host.PMID 23897706Read ↗

Evaluating the association of multiple single nucleotide polymorphisms with response to gemcitabine and platinum combination chemotherapy in urothelial carcinoma of the bladder .Semantic proximity Read ↗

The emerging landscape of germline variants in urothelial carcinoma: Implications for genetic testingSemantic proximity Read ↗

Potentially functional variants in nucleotide excision repair pathway genes predict platinum treatment response of Chinese ovarian cancer patients.Semantic proximity Read ↗

A germline predictive signature of response to platinum chemotherapy in esophageal cancer.Semantic proximity Read ↗

Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer.Semantic proximity Read ↗

Commentary on "DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma."Semantic proximity Read ↗

Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients.Semantic proximity Read ↗

DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma.Semantic proximity Read ↗

TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab.Semantic proximity Read ↗

Toxicity related to immunotherapy in urothelial cancer: Tumour genetic risk variants.Semantic proximity Read ↗

Cumulative genetic risk predicts platinum/taxane-induced neurotoxicity.Semantic proximity Read ↗

Toxicity related to immunotherapy in urothelial cancer: Tumour genetic risk variantsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.